Camden Partners' early-stage venture fund makes final close - Technical.ly Baltimore

Business

Dec. 21, 2017 12:29 pm

Camden Partners’ early-stage venture fund makes final close

Leaders seeking to commercialize more research often cite a need for more early-stage funding. The Nexus Fund is focused on biomedical startups that were born at institutions in Maryland.

Nexus Fund team (L to R): David Oros, Shamita Etienne-Cummings, Dr. Justin Hanes, Dr. Jacob Vogelstein, George Petrocheilos, David Warnock, Aris Melissaratos, Dr. Bert Vogelstein, Dr. Youseph Yazdi, Dr. Adam Riess, Jennifer Elisseeff, Dr. Henry Brem.

(Photo by Mark L. Dennis/Courtesy Camden Partners)

Camden Partners announced the final close of its venture capital fund that is seeking to invest in startups that originated at Maryland’s research institutions.

The Camden Partners Nexus Fund is focusing on supporting early stage startups commercializing biomedical technology coming from research institutions like Johns Hopkins and the University of Maryland, according to a press release.

A lack of early stage funding is frequently cited as a barrier for startups looking bring research out of the lab and into the market, so the appearance of a Baltimore-based fund is notable for the tech-transfer community. For Inner Harbor–based Camden Partners, it marks the first foray into an early stage venture capital fund for a firm that normally focuses on later-stage deals.

The fund launched in 2016, and was cofounded by R. Jacob Vogelstein and George Petrocheilos, who are working on the fund within Camden Partners. Joining as cofounders were Camden’s senior partner David Warnock and entrepreneur David Oros. The name has since changed from the Exelixis Fund to the Nexus Fund.

The fund also assembled an advisory board made up of Maryland experts to assist in sourcing deals and with technical due diligence. Among the members are Nobel Prize–winning astrophysicist Adam Riess, Johns Hopkins neurosurgeon Harry Brem, Nova Pharma cofounder Solomon Snyder and Geoff Ling, the former director of DARPA’s biomedical technologies office.

A dollar amount of the final close was not disclosed, but the release states investments came from a mix of investors and family offices. Nexus is looking to invest between $500,000 and $2.5 million per deal over about 10–12 deals, according to Camden Partners.

The fund currently has investments in six companies, according to Camden. Among them is Sisu Global Health, a medical device startup whose founders relocated to Baltimore from Michigan, and is expanding sales of its blood autotransfusion device in Africa. Canton-based Personal Genome Diagnostics, a Johns Hopkins spinout, also received investment, as well as University of Maryland BioPark–based eNeura, which makes a device to treat migraines. Additional investments include Ashvattha Therapeutics, Oprheris and Cage Pharmaceuticals, which is developing new drugs targeting the growth of tumors.

Advertisement

Companies: Camden Partners
-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

Ion Storage Systems raises $8M for solid state battery development

UMB startup NextStep Robotics raises $600K for device treating foot drop

Xometry raises $50M, led by Owings Mills-based Greenspring Associates

SPONSORED

Baltimore

Building a data acquisition system? Don’t make this mistake

Baltimore, MD

SmartLogic

Account Executive (Baltimore)

Apply Now
Baltimore, MD 21201

14 West

Junior Database Administrator

Apply Now

Baltimore’s ABS Capital Partners leads $23M Series A for Florida cybersecurity company

Female founders get far less VC funding than men. Here’s a look at the numbers in Baltimore

eBay founder’s Omidyar Network invests in Baltimore-based Terbium Labs

SPONSORED

Baltimore

How SmartLogic accelerated these startups’ product growth trajectories

Baltimore

14 West

Senior Java Software Engineer

Apply Now
Baltimore, MD 21201

14 West

Senior Data Engineer

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!